new-mims-resource-for-adhd-prescribing 2023-11-24T16:40:16.511Z 9e36e9bc-220b-41d6-9d5c-600921d39e72 mas_evidence_types:Media%20and%20commentaries Media and commentaries MIMS has produced a new table summarising the different formulations of licensed ADHD medications (methylphenidate; lisdexamfetamine; dexamfetamine, atomoxetine, guanfacine) available in the UK and their place in therapy. <p>Used in conjunction with the MIMS drug shortages tracker, the table may be helpful in identifying preparations currently available to prescribers in the UK. Information on drug shortages is also available from the SPS Medicines Supply Tool.</p> https://www.medicinesresources.nhs.uk/new-mims-resource-for-adhd-prescribing.html <p><a href="https://www.mims.co.uk/drug-shortages-live-tracker/article/1581516">MIMS drug shortages tracker </a></p> <p><a href="https://www.sps.nhs.uk/home/tools/medicines-supply-tool/">SPS Medicines Supply Tool </a></p> <p>&nbsp;</p> https://www.mims.co.uk/attention-deficit-hyperactivity-disorder-adhd-treatments/neurology/article/1847495 2023-11-21T00:00:00Z 2023-11-24T16:36:29.589Z